PTPA and Alzheimer disease: The most highly ranked transcription factor was SET nuclear proto-oncogene (SET), an endogenous inhibitor of the protein phosphatase 2A (PP2A), which is a major tau dephosphorylating enzyme in the brain largely implicated in the pathogenesis of AD (Theendakara et al., 2017).